Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Tasha Sims

1PUBLICATIONS

22CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 18, 2024

First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies.

Nehal J Lakhani, Kyriakos P Papadopoulos, Melissa Lynne Johnson

Pageof 1

Frequent Collaborators

1 joint publications

Nehal J Lakhani

1 joint publications

Kyriakos P Papadopoulos

1 joint publications

Melissa Lynne Johnson

1 joint publications

Haeseong Park

1 joint publications

Ding Wang

1 joint publications

Timothy A Yap

1 joint publications

Afshin Dowlati

1 joint publications

Robert G Maki

1 joint publications

Susanna Ulahannan

1 joint publications

Filipa Lynce

Frequent Collaborators

1 joint publications

Nehal J Lakhani

1 joint publications

Kyriakos P Papadopoulos

1 joint publications

Melissa Lynne Johnson

1 joint publications

Haeseong Park

Top Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on : Dec 16, 2022

See more related videos

Top Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on : Dec 16, 2022

See more related videos